Submissions are open for the upcoming issue.

Molecular Medicine Peer-reviewed scientific journal

Found: 14

ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2026 · pp. 9–14

Age-related changes in 5xFAD microglia

Introduction. Microglia initiate and play a key role in neuroinflammation, which is currently considered one of the main mechanisms of neurodegeneration in Alzheimer’s disease. The aim of this study was to analyze the morphofunctional characteristics of microg…

10.29296/24999490-2026-03-02Details ↗
ОБЗОР2025 · pp. 16–26

Neurodegenerative diseases as a target for genome editing: from preclinical studies to clinical practice

Objective. To analyze the current state of preclinical and clinical studies in genome editing for neurodegenerative diseases, evaluate its potential impact on clinical practice, and examine ethical aspects of these technologies’ application. Material and metho…

10.29296/24999490-2025-01-02Details ↗
ОБЗОР2024 · pp. 31–39

USING ARTIFICIAL INTELLIGENCE FOR BIOMARKER ANALYSIS IN CLINICAL DIAGNOSTICS

Introduction. Artificial intelligence (AI) technologies are becoming crucial in clinical diagnostics due to their ability to process and interpret large volumes of data. The implementation of AI for biomarker analysis opens new opportunities in personalized me…

10.29296/24999490-2024-05-04Details ↗
ОБЗОР2024 · pp. 16–22

Biomarkers of oxidative stress and proteopathies in the diagnosis of neurodegenerative diseases

Introduction. Despite numerous studies in the field of neurodegenerative diseases, the exact mechanisms of these processes have not yet been identified. The purpose of this review is to analyze the methodological approaches necessary to revise the traditional …

10.29296/24999490-2024-02-03Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2022

SIRTUINS: PREDICTIVE MOLECULAR DIAGNOSIS OF ALZHEIMER’S DISEASE IN LONG-LIVER

The incidence of Alzheimer’s disease (AD) in people older 80 years old is 52%. Consequently, the predictive diagnostic of this neurodegenerative disease in long-liver is the actual goal of molecular medicine and gerontology. The aim of the research is to compa…

10.29296/24999490-2022-01-05Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2021

FEATURES OF EXPRESSION OF β-AMYLOID IN CEREBRAL ENDOTHELIAL CELLS IN EXPERIMENTAL ALZHEIMER’S DISEASE

Introduction. The formation of neurofibrillary plexuses and the accumulation of senile plaques in the parenchyma and cerebral vessels are the key pathological signs of Alzheimer’s disease presenting a neurodegenerative disease. The main component of senile pla…

10.29296/24999490-2021-02-04Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2020

EVALUATION OF THE OXIDATIVE MODIFICATION OF BLOOD PLASMA PROTEINS AND LEUKOCYTES IN ALZHEIMER’S DISEASE

Introduction. The development of neurodegeneration in Alzheimer’s disease is inextricably linked with oxidative stress, a marker of which is oxidative protein modification. In the tissues of the brain, cerebrospinal fluid and plasma in Alzheimer’s disease, an …

10.29296/24999490-2020-05-06Details ↗
ОБЗОР2020

NEURODEGENERATIVE DISEASES AND BIOMEDICAL CELL PRODUCTS: RELEVANCE, DIRECTIONS, AND PROBLEMS OF DEVELOPMENT

Progress in clinical research and medicine has contributed to a significant reduction in the worldwide mortality rate. Currently, the strategy of developed countries is directed at increasing expectancy and improving life quality. As a consequence, the modern …

10.29296/24999490-2020-04-02Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2020

RELATIONSHIP BETWEEN OXIDATIVE PROTEIN MODIFICATION AND THE ACTIVITY OF LYSOSOMAL CYSTEINE PROTEINASES IN BLOOD PLASMA AND LEUKOCYTES IN ALZHEIMER’S DISEASE

Introduction. Revealing the relationship between the severity of oxidative stress and the activity of cathepsins in tissues (plasma and blood cells) readily available for the diagnosis of Alzheimer’s disease can be useful for understanding the pathogenesis of …

10.29296/24999490-2020-06-07Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2017

AΒ42 – APROMISSING NON-INVASIVE MARKER FOR LIFE-TIME DIAGNOSIS OF ALZHEIMER’S DISEASE

Introduction. Alzheimer's disease (AD) is a socially important neurodegenerative disease. The prevalence rate of AD is increasing over recent years. According to the hypothesis concerning AD to be a systematic disease its manifestation can be detected in vario…

Details ↗
ПЕРЕДОВАЯ СТАТЬЯ2016

MOLECULAR AND CELLULAR MECHANISMS OF ALZHEIMER’S DISEASE

Alzheimer's disease being the socially significant neurodegenerative disease of the elderly, ranks 6th on the causes of death among somatic pathologies. The molecular mechanisms of Alzheimer's disease still remain unexplored until the end, and the efficacy of …

Details ↗
Research article2012

SIGNALING MOLECULES: THE PLACE AND THE ROLE IN PERSONALIZED DIAGNOSTICS,TREATMENT AND PREVENTION OF SOCIALLY SIGNIFICANT DISEASES

This review is devoted to availability of investigation of expression of signaling molecules in personalized and predictive medicine. As exemplified in cardio-vascular pathology (hypertonic disease, myocardial infarction), Alzheimer’s disease and chronic obstr…

Details ↗ PDF
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ

SIRTUINS: PREDICTIVE MOLECULAR DIAGNOSIS OF ALZHEIMER’S DISEASE IN LONG-LIVER

The incidence of Alzheimer’s disease (AD) in people older 80 years old is 52%. Consequently, the predictive diagnostic of this neurodegenerative disease in long-liver is the actual goal of molecular medicine and gerontology. The aim of the research is to compa…

10.29296/24999490-2022-01-05Details ↗

Article search and quick navigation

Navigation